"The study will give these countries more treatment options," said Dr. Lynne M. Mofenson, the associate branch chief for clinical research in the pediatric, adolescent and maternal AIDS branch at National Institute of Child Health and Human Development.
The government in Thailand, where the study was conducted, should soon implement policy changes based on the study, according to Lallemant.
"The Thai government is modifying their treatment recommendation to be based on what this study shows," Mofenson said.
With this new treatment option, transmission rates in Thailand should decrease, according to Mofenson.
Treatment will not change in the United States and other developed countries that can afford the more elaborate standard regimen, according to Mofenson.
The full study will be printed in the October 5 New England Journal of Medicine.